CLINT NACAR: Open Payments
NPI 1609466259 · CERRITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,467 in 150 payments from 14 companies in 2025. Trend: 2023 $3,659 · 2024 $3,859 · 2025 $3,467
Food & beverage: $2,848Travel & lodging: $619
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 22 | $1,087 |
| Otsuka America Pharmaceutical, Inc. | 18 | $502 |
| ABBVIE INC. | 34 | $471 |
| Vanda Pharmaceuticals Inc. | 16 | $334 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $270 |
| E.R. Squibb & Sons, L.L.C. | 8 | $190 |
| Lundbeck LLC | 8 | $153 |
| Axsome Therapeutics, Inc. | 7 | $135 |
| Neurocrine BioSciences, Inc. | 4 | $122 |
| Corium, LLC | 3 | $78 |
Products named: SPRAVATO, REXULTI, VRAYLAR, FANAPT, CAPLYTA, INVEGA SUSTENNA, COBENFY, Auvelity.
Industry payments across CA — which companies pay providers there.
